×
More Charts Below
Personalis Basic EPS 2018-2024 | PSNL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Recent Trends
Personalis basic eps from 2018 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$15.5B
Dr Reddy's Laboratories (RDY)
$11.4B
BridgeBio Pharma (BBIO)
$6.4B
Bausch Health Cos (BHC)
$1.9B
Supernus Pharmaceuticals (SUPN)
$1.7B
Amphastar Pharmaceuticals (AMPH)
$1.1B
Taysha Gene Therapies (TSHA)
$254M
Assembly Biosciences (ASMB)
$75M
Sol-Gel Technologies (SLGL)
$15M
Evoke Pharma (EVOK)
$3M
Teligent (TLGT)
$0M